The knowledge-integrated network biomarkers discovery for major adverse cardiac events
- PMID: 18665624
- PMCID: PMC2854538
- DOI: 10.1021/pr8002886
The knowledge-integrated network biomarkers discovery for major adverse cardiac events
Abstract
The mass spectrometry (MS) technology in clinical proteomics is very promising for discovery of new biomarkers for diseases management. To overcome the obstacles of data noises in MS analysis, we proposed a new approach of knowledge-integrated biomarker discovery using data from Major Adverse Cardiac Events (MACE) patients. We first built up a cardiovascular-related network based on protein information coming from protein annotations in Uniprot, protein-protein interaction (PPI), and signal transduction database. Distinct from the previous machine learning methods in MS data processing, we then used statistical methods to discover biomarkers in cardiovascular-related network. Through the tradeoff between known protein information and data noises in mass spectrometry data, we finally could firmly identify those high-confident biomarkers. Most importantly, aided by protein-protein interaction network, that is, cardiovascular-related network, we proposed a new type of biomarkers, that is, network biomarkers, composed of a set of proteins and the interactions among them. The candidate network biomarkers can classify the two groups of patients more accurately than current single ones without consideration of biological molecular interaction.
Figures






References
-
- Malik G, Rojahn E, Ward MD, Gretzer MB, Partin AW, Semmes OJ, Veltri RW. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression. Prostate. 2007;67(14):1565–75. - PubMed
-
- Oh JH, Nandi A, Gurnani P, Knowles L, Schorge J, Rosenblatt KP, Gao JX. Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer. J Bioinf Comput Biol. 2006;4(6):1159–79. - PubMed
-
- Paweletz CP, Liotta LA, Petricoin EF., 3rd New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Urology. 2001;57(4 Suppl. 1):160–3. - PubMed
-
- Wulfkuhle JD, McLean KC, Paweletz CP, Sgroi DC, Trock BJ, Steeg PS, Petricoin EF. New approaches to proteomic analysis of breast cancer. Proteomics. 2001;1(10):1205–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources